The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
The J&J-Auris tie-up will yield a huge return for investors who went in big.
The preponderance of large deals comes partly as a consequence of soaring market valuations; paradoxically, it is also a cause of them.
Either buyers are being pickier or the pool of targets is dwindling.